NCT05631886
- Conditions
- Disease Attributes, EphA2 Overexpression, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China
Clinical trial condition
TP53 R248Q
Explore clinical trials studying TP53 R248Q. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study